Trial site
Japanese Red Cross Kumamoto Hospital
- 18running trials
- 4closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease8 trials
- Ulcerative colitis7 trials
- Heart failure2 trials
- Lupus (SLE)2 trials
- Stroke2 trials
- Chronic kidney disease1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 316 trials
- Phase 22 trials
- Phase 2/32 trials
- Status
- Recruiting9 trials
- Active, not recruiting7 trials
- Completed4 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC7 trials
- Takeda3 trials
- Biogen2 trials
- Boehringer Ingelheim2 trials
- Pfizer2 trials
- and 6 more
Running trials
Recruiting
Recruiting
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Recruiting
Active, not recruiting
Recruiting
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Recruiting
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease6 recruiting
- Ulcerative colitis3 recruiting
- Heart failure2 recruiting
- Lupus (SLE)1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Stroke1 recruiting
Closed trials
Completed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Completed
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Completed
Completed
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Site data: ClinicalTrials.govUpdated 17 Nov 2026